Literature DB >> 22358334

Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts.

Yvonne Geldmacher1, Katrin Splith, Igor Kitanovic, Hamed Alborzinia, Suzan Can, Riccardo Rubbiani, M Ali Nazif, Pascal Wefelmeier, Aram Prokop, Ingo Ott, Stefan Wölfl, Ines Neundorf, William S Sheldrick.   

Abstract

Half-sandwich organorhodium(III) complexes and their trichloridorhodium(III) counterparts are potent anticancer agents that enhance the formation of reactive oxygen species and invoke a strong induction of apoptosis in leukemia cells. The antiproliferative activity towards human MCF-7 and HT-29 adenocarcinoma cells of novel nonintercalating complexes containing the 5-substituted phenanthroline ligands 5,6-dimethylphenanthroline, 5-chlorophenanthroline, and 5-nitrophenanthroline (phen*) increases dramatically in the order [(η(5)-C(5)Me(5))IrCl(phen*)](CF(3)SO(3)) < [(η(5)-C(5)Me(5))RhCl(phen*)](CF(3)SO(3)) < mer-[RhCl(3)(DMSO)(phen*)] (DMSO is dimethyl sulfoxide). Improved activity was also achieved by attaching a cell-penetrating peptide to the dipyrido[3,2-a:2',3'-c]phenazine (dppz) ligand of an organorhodium(III) complex. Whereas 5-substitution led to significant improvements in the activity of the organoiridium(III) and trichloridorhodium(III) compounds in comparison with the parent phenanthroline complex, the IC(50) values of their organorhodium(III) counterparts remained effectively invariable. The high activities of the trichloridorhodium(III) complexes (IC(50) = 0.06-0.13 μM) were accompanied by pronounced selectivity towards human cancer cells in comparison with immortalized HEK-293 cells. In contrast, [(η(5)-C(5)Me(5))RhCl(5,6-Me(2)phen)](CF(3)SO(3)) (phen is phenanthroline) was markedly more active towards BJAB lymphoma cells than ex vivo healthy leukocytes and caused an immediate decrease in cellular adhesion possibly associated with interactions with membrane proteins. Its dppz analogue invoked an initial increase in glycolysis to compensate for reduced respiration before inducing a delayed onset of cell death. Strong antimitochondrial activity with respiration impairment and release of cytochrome c was established for both complexes. © SBIC 2012

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22358334     DOI: 10.1007/s00775-012-0883-2

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  24 in total

1.  Isolation of biogenetically competent mitochondria from mammalian tissues and cultured cells.

Authors:  Erika Fernández-Vizarra; Manuel J López-Pérez; José A Enriquez
Journal:  Methods       Date:  2002-04       Impact factor: 3.608

2.  Influence of the metal complex-to-peptide linker on the synthesis and properties of bioactive CpMn(CO)3 peptide conjugates.

Authors:  Katrin Splith; Ines Neundorf; Wanning Hu; Harmel W Peindy N'Dongo; Vera Vasylyeva; Klaus Merz; Ulrich Schatzschneider
Journal:  Dalton Trans       Date:  2010-01-22       Impact factor: 4.390

3.  Monitoring of cellular signalling and metabolism with modular sensor-technique: the PhysioControl-Microsystem (PCM).

Authors:  B Wolf; M Brischwein; W Baumann; R Ehret; M Kraus
Journal:  Biosens Bioelectron       Date:  1998-03-15       Impact factor: 10.618

4.  On-line control of cellular adhesion with impedance measurements using interdigitated electrode structures.

Authors:  R Ehret; W Baumann; M Brischwein; A Schwinde; B Wolf
Journal:  Med Biol Eng Comput       Date:  1998-05       Impact factor: 2.602

5.  Cell-selective, apoptosis-inducing rhodium(III) crown thiaether complexes.

Authors:  Ruth Bieda; Mara Dobroschke; Annika Triller; Ingo Ott; Marc Spehr; Ronald Gust; Aram Prokop; William S Sheldrick
Journal:  ChemMedChem       Date:  2010-07-05       Impact factor: 3.466

6.  Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.

Authors:  Stefan Wirth; Christoph J Rohbogner; Marcin Cieslak; Julia Kazmierczak-Baranska; Stefan Donevski; Barbara Nawrot; Ingo-Peter Lorenz
Journal:  J Biol Inorg Chem       Date:  2009-12-19       Impact factor: 3.358

7.  Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.

Authors:  Anwen M Krause-Heuer; Renate Grünert; Sybill Kühne; Magdalena Buczkowska; Nial J Wheate; Delphine D Le Pevelen; Leanne R Boag; Dianne M Fisher; Jana Kasparkova; Jaroslav Malina; Patrick J Bednarski; Viktor Brabec; Janice R Aldrich-Wright
Journal:  J Med Chem       Date:  2009-09-10       Impact factor: 7.446

8.  Structure-activity relationships and DNA binding properties of apoptosis inducing cytotoxic rhodium(III) polypyridyl complexes containing the cyclic thioether [9]aneS(3).

Authors:  Ruth Bieda; Ingo Ott; Mara Dobroschke; Aram Prokop; Ronald Gust; William S Sheldrick
Journal:  J Inorg Biochem       Date:  2009-01-22       Impact factor: 4.155

9.  Metal complexes as DNA intercalators.

Authors:  Hong-Ke Liu; Peter J Sadler
Journal:  Acc Chem Res       Date:  2011-03-29       Impact factor: 22.384

10.  Real-time monitoring of cisplatin-induced cell death.

Authors:  Hamed Alborzinia; Suzan Can; Pavlo Holenya; Catharina Scholl; Elke Lederer; Igor Kitanovic; Stefan Wölfl
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

View more
  5 in total

1.  Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.

Authors:  Adam J Millett; Abraha Habtemariam; Isolda Romero-Canelón; Guy J Clarkson; Peter J Sadler
Journal:  Organometallics       Date:  2015-03-25       Impact factor: 3.876

2.  Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.

Authors:  Anja Gronewold; Mareike Horn; Ivan Ranđelović; József Tóvári; Sergio Muñoz Vázquez; Klaus Schomäcker; Ines Neundorf
Journal:  ChemMedChem       Date:  2016-11-18       Impact factor: 3.466

3.  Design and biological characterization of novel cell-penetrating peptides preferentially targeting cell nuclei and subnuclear regions.

Authors:  Anja Gronewold; Mareike Horn; Ines Neundorf
Journal:  Beilstein J Org Chem       Date:  2018-06-07       Impact factor: 2.883

4.  Building up PtII -Thiosemicarbazone-Lysine-sC18 Conjugates.

Authors:  Alexander Haseloer; Tamara Lützenburg; Joss Pepe Strache; Jörg Neudörfl; Ines Neundorf; Axel Klein
Journal:  Chembiochem       Date:  2020-11-06       Impact factor: 3.164

5.  Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2.

Authors:  Christina Chuong; Christine M DuChane; Emily M Webb; Pallavi Rai; Jeffrey M Marano; Chad M Bernier; Joseph S Merola; James Weger-Lucarelli
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.